Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $340.7800 (1.9%) ($332.8400 - $341.1700) on Thu. Mar. 8, 2018. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.05% (three month average) | | RSI | 54 | | Latest Price | $340.7800(1.9%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 1.2% a day on average for past five trading days. | | Weekly Trend | REGN advances 1.8% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Value stock sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | | Factors Impacting REGN price | REGN will decline at least -1.025% in a week (0% probabilities).
UUP(-10%) TLT(-7%) VIXM(-6%) TIP(-1%) SHY(-1%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.025% (StdDev 2.05%) | | Hourly BBV | 0 () | | Intraday Trend | 1.9% | | | | | |
|
| 5 Day Moving Average | $334.61(1.84%) | | 10 Day Moving Average | $328.86(3.62%) | | 20 Day Moving Average | $328.22(3.83%) | | To recent high | -13.5% | | To recent low | 7.9% | | Market Cap | $36.132b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |